Nomura Asset Management’s BeOne Medicines Ltd ONC Stock Holding History

Nomura Asset Management’s Portfolio ONC Stock Details ONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-4,140	Closed	-$759K	–	1533
2022 Q3	$558K	Buy	4,140 +310	+8%	+$53.2K	﹤0.01%	851
2022 Q2	$620K	Buy	3,830 +270	+8%	+$42.2K	﹤0.01%	865
2022 Q1	$671K	Hold	3,560	–	–	﹤0.01%	873
2021 Q4	$965K	Hold	3,560	–	–	﹤0.01%	848
2021 Q3	$1.29M	Buy	3,560 +310	+10%	+$101K	0.01%	788
2021 Q2	$1.12M	Sell	3,250 -144,713	-98%	-$47.9M	0.01%	841
2021 Q1	$51.5M	Sell	147,963 -150	-0.1%	-$49.7K	0.33%	72
2020 Q4	$38.3M	Sell	148,113 -9,130	-6%	-$2.51M	0.26%	89
2020 Q3	$45M	Buy	157,243 +4,525	+3%	+$1.06M	0.35%	61
2020 Q2	$28.8M	Buy	152,718 +145,938	+2,152%	+$23.8M	0.24%	91
2020 Q1	$835K	Buy	6,780 +910	+16%	+$142K	0.01%	730
2019 Q4	$973K	Hold	5,870	–	–	0.01%	792
2019 Q3	$719K	Buy	5,870 +900	+18%	+$120K	0.01%	828
2019 Q2	$616K	Hold	4,970	–	–	0.01%	854
2019 Q1	$656K	Hold	4,970	–	–	0.01%	819
2018 Q4	$697K	Buy	+4,970	New	+$659K	0.01%	780

Other funds holding ONC

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

CII

Capital International Inc Los Angeles, California $14.3B AUM 34.19% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Nomura Asset Management's ONC Position: Q4 2022 in Review

Nomura Asset Management sold out of BeOne Medicines Ltd (ONC) in Q4 2022, closing a stake of 4,140 shares — an estimated $759K sold.

Nomura Asset Management first reported a position in ONC in Q4 2018 and held it in 16 quarters. The position peaked at $51.5M in Q1 2021. 212 funds tracked by Wall St. Rank hold ONC as of Q4 2022.

Nomura Asset Management reported no remaining BeOne Medicines Ltd position as of Q4 2022 after selling out during the quarter.
Nomura Asset Management sold 4,140 BeOne Medicines Ltd shares in Q4 2022, an estimated $759K.
Nomura Asset Management first reported a position in BeOne Medicines Ltd in Q4 2018 and held it in 16 quarters.
Nomura Asset Management's BeOne Medicines Ltd position peaked at $51.5M in Q1 2021.
212 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q4 2022.

Based on Nomura Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.